To hear about similar clinical trials, please enter your email below
Trial Title:
Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies
NCT ID:
NCT05602103
Condition:
Malignancies
Cardiovascular Diseases
Children, Only
Conditions: Official terms:
Neoplasms
Cardiovascular Diseases
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Drug
Intervention name:
use of anticancer drugs in monotherapy or in combination therapy
Description:
Cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs will
be identify and describe
Summary:
Little is known about cancer therapy-related cardiac dysfunction occuring in children
treated by anticancer drugs for malignancies. Here the investigators use VigiBase
(http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual
safety case reports, to identify and describe cases of cancer therapy-related cardiac
dysfunction associated with anticancer drugs.
Criteria for eligibility:
Study pop:
Cases reported in the World Health Organization (WHO) database of individual safety case
reports (vigibase) related to children and reported, or not, cancer therapy-related
cardiac dysfunction
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- cases reported in the World Health Organization (WHO) database of individual safety
case reports (vigibase)
- related to children
- and reported, or not, cancer therapy-related cardiac dysfunction
Exclusion Criteria:
- cases reported in the World Health Organization (WHO) database of individual safety
case reports (vigibase) related to adult patients
Gender:
All
Minimum age:
0 Years
Maximum age:
18 Years
Healthy volunteers:
No
Start date:
November 5, 2024
Completion date:
January 6, 2025
Lead sponsor:
Agency:
University Hospital, Caen
Agency class:
Other
Source:
University Hospital, Caen
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05602103
